Ocimum Biosolutions and Bio Enterprise Asia form a strategic alliance to set up R&D facilities at the ICICI knowledge park
Ocimum Biosolutions and BioEnterprise Asia signed an MoU to form a Joint Venture company called Ocimum BioEnterprise Labs. The MoUs were exchanged between Dr. Gurinder Shahi, CEO of Bioenterprise Asia and Anuradha Acharya, CEO of Ocimum Biosolutions Ltd., at the International conference on emerging trends on biotechnology and were handed over by the Chief Minister Shri Chandra Babu Naidu. Ocimum BioEnterprise Labs will set up R&D facilities at the ICICI knowledge park.
(PRWEB) May 7, 2002
Hyderabad, May 3rd, 2002
Ocimum Biosolutions and BioEnterprise Asia signed an MoU to form a Joint Venture company called Ocimum BioEnterprise Labs. The MoUs were exchanged between Dr. Gurinder Shahi, CEO of Bioenterprise Asia and Anuradha Acharya, CEO of Ocimum Biosolutions Ltd., at the International conference on emerging trends on biotechnology and were handed over by the Chief Minister Shri Chandra Babu Naidu. Ocimum BioEnterprise Labs will set up R&D facilities at the ICICI knowledge park. “The collaborative R&D project is being established to enable both Ocimum BioSolutions and AP BioEnterprise Asia to benefit maximally from the strengths and capabilities of both the parties” said Anuradha Acharya. “ Areas of interest will include technology and product development in relation to drugs and genome based diagnostics” added Subash Lingareddy, President and CFO of Ocimum Biosolutions.
The BioEnterprise Asia ("BEA") Group is a consortium of life science enterprises dedicated to identifying, nurturing and managing the development of innovative new technologies and high growth enterprises in healthcare, the life sciences and related technology areas. The BEA Group understands healthcare, biotechnology and the life sciences. They take a proactive market-oriented stance in identifying and exploiting innovative technologies and high growth technology business opportunities in Asia. “ BioEnterprise Asia recognizes the tremendous untapped potential of scientific insight and nascent technologies in India,” said Dr. Gurinder Shahi.
BEA Group enterprises currently include: Lynk Biotechnologies in the Proteomics and drug development arena and Asia Pacific Genomics in the Genomics arena and others in the areas of medical device and biomedical IT, surfactants and specialty biomaterials and BioInformatics and molecular modeling arena.
Ocimum Biosolutions is a life sciences research and development company with focus on bioinformatics and contract research services with operations both in the USA and India. Ocimum Biosolutions has its U. S. Headquarters in Indianapolis, Indiana and a branch office at Newport Beach, California. The Indian arm of Ocimum Biosolutions is located in Hyderabad. The company's primary focus is to be a one-stop destination for Bioinformatics consulting needs and also on development of key ready-to-use Bioinformatics software modules, contract research and training.
©2001 Ocimum Biosolutions Ltd. All Rights Reserved.
Webmaster
